Virios Therapeutics Announces Halt To At-The-Market Offering Sales Under Capital On Demandtm Sales Agreement
Portfolio Pulse from Benzinga Newsdesk
Virios Therapeutics has announced a halt to its at-the-market offering sales under its Capital on Demand sales agreement.
August 14, 2023 | 11:06 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Virios Therapeutics' decision to halt its at-the-market offering sales could potentially impact its stock price.
The halt to at-the-market offering sales by Virios Therapeutics could lead to a decrease in liquidity, which may negatively impact the stock price in the short term. However, the long-term impact will depend on the company's future actions and market conditions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100